C167H259F3N24O13S — CID 158333276
4-tert-butyl-6-[(1-methylpiperidin-4-yl)methyl]pyrimidine;4-tert-butyl-2-(1-methylpiperidin-4-yl)oxypyridine;4-tert-butyl-2-(1-methylsulfonylpiperidin-4-yl)oxypyridine;3-tert-butyl-5-(oxolan-3-ylmethyl)pyridine;(3S)-4-[(3-tert-butylphenyl)methyl]-3-methyloxane;bis(1-[4-[(4-tert-butyl-2-pyridinyl)oxy]piperidin-1-yl]ethanone);1-[4-[(6-tert-butylpyrimidin-4-yl)amino]piperidin-1-yl]ethanone;1-[3-[(6-tert-butylpyrimidin-4-yl)methyl]pyrrolidin-1-yl]ethanone;4-tert-butyl-6-(pyrrolidin-3-ylmethyl)pyrimidine;4-tert-butyl-2-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridine (PubChem CID 158333276) has the molecular formula C167H259F3N24O13S and a molecular weight of 2900.12 g/mol. Its IUPAC name is 4-tert-butyl-6-[(1-methylpiperidin-4-yl)methyl]pyrimidine;4-tert-butyl-2-(1-methylpiperidin-4-yl)oxypyridine;4-tert-butyl-2-(1-methylsulfonylpiperidin-4-yl)oxypyridine;3-tert-butyl-5-(oxolan-3-ylmethyl)pyridine;(3S)-4-[(3-tert-butylphenyl)methyl]-3-methyloxane;bis(1-[4-[(4-tert-butyl-2-pyridinyl)oxy]piperidin-1-yl]ethanone);1-[4-[(6-tert-butylpyrimidin-4-yl)amino]piperidin-1-yl]ethanone;1-[3-[(6-tert-butylpyrimidin-4-yl)methyl]pyrrolidin-1-yl]ethanone;4-tert-butyl-6-(pyrrolidin-3-ylmethyl)pyrimidine;4-tert-butyl-2-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridine.
| Compound Name | 4-tert-butyl-6-[(1-methylpiperidin-4-yl)methyl]pyrimidine;4-tert-butyl-2-(1-methylpiperidin-4-yl)oxypyridine;4-tert-butyl-2-(1-methylsulfonylpiperidin-4-yl)oxypyridine;3-tert-butyl-5-(oxolan-3-ylmethyl)pyridine;(3S)-4-[(3-tert-butylphenyl)methyl]-3-methyloxane;bis(1-[4-[(4-tert-butyl-2-pyridinyl)oxy]piperidin-1-yl]ethanone);1-[4-[(6-tert-butylpyrimidin-4-yl)amino]piperidin-1-yl]ethanone;1-[3-[(6-tert-butylpyrimidin-4-yl)methyl]pyrrolidin-1-yl]ethanone;4-tert-butyl-6-(pyrrolidin-3-ylmethyl)pyrimidine;4-tert-butyl-2-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridine |
|---|---|
| PubChem CID | 158333276 |
| Molecular Formula | C167H259F3N24O13S |
| Molecular Weight | 2900.12 g/mol |
| Exact Mass | 2898.00 |
| IUPAC Name | 4-tert-butyl-6-[(1-methylpiperidin-4-yl)methyl]pyrimidine;4-tert-butyl-2-(1-methylpiperidin-4-yl)oxypyridine;4-tert-butyl-2-(1-methylsulfonylpiperidin-4-yl)oxypyridine;3-tert-butyl-5-(oxolan-3-ylmethyl)pyridine;(3S)-4-[(3-tert-butylphenyl)methyl]-3-methyloxane;bis(1-[4-[(4-tert-butyl-2-pyridinyl)oxy]piperidin-1-yl]ethanone);1-[4-[(6-tert-butylpyrimidin-4-yl)amino]piperidin-1-yl]ethanone;1-[3-[(6-tert-butylpyrimidin-4-yl)methyl]pyrrolidin-1-yl]ethanone;4-tert-butyl-6-(pyrrolidin-3-ylmethyl)pyrimidine;4-tert-butyl-2-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridine |
| SMILES | CC(=O)N1CCC(Cc2cc(C(C)(C)C)ncn2)C1.CC(=O)N1CCC(Nc2cc(C(C)(C)C)ncn2)CC1.CC(=O)N1CCC(Oc2cc(C(C)(C)C)ccn2)CC1.CC(=O)N1CCC(Oc2cc(C(C)(C)C)ccn2)CC1.CC(C)(C)c1cc(CC2CCNC2)ncn1.CC(C)(C)c1ccnc(OC2CCN(CC(F)(F)F)CC2)c1.CC(C)(C)c1ccnc(OC2CCN(S(C)(=O)=O)CC2)c1.CC(C)(C)c1cncc(CC2CCOC2)c1.CN1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.CN1CCC(Oc2cc(C(C)(C)C)ccn2)CC1.C[C@@H]1COCCC1Cc1cccc(C(C)(C)C)c1 |
| InChI | InChI=1S/C17H26O.C16H23F3N2O.2C16H24N2O2.C15H24N4O.C15H23N3O.C15H25N3.C15H24N2O3S.C15H24N2O.C14H21NO.C13H21N3/c1-13-12-18-9-8-15(13)10-14-6-5-7-16(11-14)17(2,3)4;1-15(2,3)12-4-7-20-14(10-12)22-13-5-8-21(9-6-13)11-16(17,18)19;2*1-12(19)18-9-6-14(7-10-18)20-15-11-13(5-8-17-15)16(2,3)4;1-11(20)19-7-5-12(6-8-19)18-14-9-13(15(2,3)4)16-10-17-14;1-11(19)18-6-5-12(9-18)7-13-8-14(15(2,3)4)17-10-16-13;1-15(2,3)14-10-13(16-11-17-14)9-12-5-7-18(4)8-6-12;1-15(2,3)12-5-8-16-14(11-12)20-13-6-9-17(10-7-13)21(4,18)19;1-15(2,3)12-5-8-16-14(11-12)18-13-6-9-17(4)10-7-13;1-14(2,3)13-7-12(8-15-9-13)6-11-4-5-16-10-11;1-13(2,3)12-7-11(15-9-16-12)6-10-4-5-14-8-10/h5-7,11,13,15H,8-10,12H2,1-4H3;4,7,10,13H,5-6,8-9,11H2,1-3H3;2*5,8,11,14H,6-7,9-10H2,1-4H3;9-10,12H,5-8H2,1-4H3,(H,16,17,18);8,10,12H,5-7,9H2,1-4H3;10-12H,5-9H2,1-4H3;5,8,11,13H,6-7,9-10H2,1-4H3;5,8,11,13H,6-7,9-10H2,1-4H3;7-9,11H,4-6,10H2,1-3H3;7,9-10,14H,4-6,8H2,1-3H3/t13-,15?;;;;;;;;;;/m1........../s1 |
| InChIKey | GQGPJWYKIJHWOG-CKSKHAGYSA-N |
| XLogP | 30.48 |
| TPSA | 397.47 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 208 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2900.12 |
| LogP ≤ 5 | 30.48 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 32 |